Global Bioinformatics Market Tends to Expand at a CAGR of 20.5% during Forecast Period 2016-2024

According to Goldstein Research, Global bioinformatics market is anticipated to grow at a CAGR of 20.5% over the forecast period 2016-2024 to reach USD 17.5 billion by 2024. Major driving factor for global bioinformatics market is the application and development of data mining techniques to solve biological problems as analyzing large biological data sets requires making sense of the data by inferring structure or generalizations from the data. However, the biggest challenge is to decide which data sets to archive and which to discard also known as data deluge. Global Bioinformatics market segmentation has been done on the basis of product type, sector, application and geography.

Global bioinformatics market segmentation based on product type, molecular medicine segment dominated the market in 2016 with 30.0% market share while preventive medicine is anticipated to grow at a faster CAGR of 25% over the forecast period due to the increasing awareness about its key specialties like aerospace medicine. Bioinformatics market is largely dominated by North America with a market size of USD 5.89 billion in 2016. Europe is the second largest market for Bioinformatics as countries like Germany and UK have huge bioinformatics market stimulated by the continuous R&D activities in the region.

Download Exclusive Sample Report: https://www.goldsteinresearch.com/request-sample/global-bioinformatics-market-size-industry-research

Market Segmentation

On the basis of our in-depth analysis, Global Bioinformatics Market can be segmented and sub-segmented as follows:

By Product Type

o Platform
o Product & Services
 Molecular Medicine
 Preventive Medicine
 Sequence analysis
 Sequence alignment
 Sequence manipulation
 Structural analysis
 Sequencing services
 Database and management
 Data Analysis
o Tools

By Sector

o Medical Bioinformatics
o Animal Bioinformatics
o Agricultural Bioinformatics
o Academics
o Other (Microbial Genome)

By Application

o Chemoinformatics and Drug Design
o Genomics
o Proteomics
o Transcriptomics
o Metabolomics
o Agriculture
o Environment
o Forensic Sciences

Based on Region

o North America (United States, Canada) {Market Share (%), Market Size (USD Billion, Adoption Rate (%)}
o Europe (UK, France, Italy, Germany, Spain, Hungary, Sweden, Russia, Poland and Rest of Europe) {Market Share (%), Market Size (USD Billion), Adoption Rate (%)}
o Middle East and Africa (GCC Countries, North Africa, South Africa and Rest of Middle East & Africa) {Market Share (%), Market Size (USD Billion), Adoption Rate (%)}
o Latin America (Brazil, Mexico and Rest of Latin America) {Market Share (%), Market Size (USD Billion), Adoption Rate (%)}
o Asia Pacific bioinformatics Market (China, Japan, India, Singapore, South Korea, Australia, New Zealand and Rest of Asia-Pacific) {Market Share (%), Market Size (USD Billion), Adoption Rate (%)}
Browse Full Report: https://www.goldsteinresearch.com/report/global-bioinformatics-market-size-industry-research

“Bioinformatics Market Outlook 2024” contains a detailed overview of the global bioinformatics market. On the basis of our in-depth analysis, market can be segmented in terms of market segmentation by product type, sector and application.

Further, for the in-depth analysis, Global Bioinformatics Market Report technology and end-user encompasses the industry growth drivers, market challenges, risk analysis, market attractiveness, BPS (Base Point Scale) analysis, Porter’s five force model and SWOT analysis.

This industry analysis report also includes competitive outlook of some of the major players profiling of companies such as Illumina Inc, Waters Corporation, Agilent Technologies, Inc, Thermo Fisher Scientific Inc., Sencel bioinformatics, S.A.F.A.N. Bioinformatics SAS, Biovia, Regeneron Pharmaceuticals, Biomax Informatics AG, Qiagen n.v., Inc, Geneva Bioinformatics SA, Noray bioinformatics SLU, etc. The company profiles include business strategy, geographical revenue distribution, major information of the companies which encompasses business outlook, products, services and industries catered, financial analysis of the company and recent developments.

Objective of Report:
To analyze and forecast market size of bioinformatics market.
To calculate the expected growth rate of bioinformatics market.
To classify and forecast bioinformatics market based on product type, sector, application and geography.

To identify market key players, driving factors, & trends of bioinformatics market with the help of SWOT Analysis.
To identify and analyze the profiles of leading players involved in the manufacturing and supplying of bioinformatics market.
To identify market opportunities for the existing and entry level players.

Overall, the report represents the global bioinformatics market trends along with market forecast that will help industry consultants, technology providers, existing players searching for expansion opportunities, new players searching possibilities and other stakeholders to align their market centric strategies according to the ongoing and expected trends in the future.

About Goldstein Research

Based in the US, Goldstein Research currently has a strong presence in the American and Asian countries. In the next five years, we strive to expand our reach to 50+ nations spanning across Europe, Asia and parts of the Middle East and Africa. We strive to realize a strong brand presence globally through our quality research and forecasting solutions.

Our mission is simple: to develop insightful business solutions, help our clients make powerful future decisions to keep them well ahead of the game which is the market, and leave a mark across businesses and communities through our well-defined ideas and clear cut forecasts. Our market research reports provide in-depth analysis of global and regional variations along with competitors’ overview.

Our analysts working on healthcare market research reports to help various tech-giants, tech start-ups and entry players to assess the current and upcoming business scenario. We believe in vigorous examination of the current market scenario and build around creative ideas and approaches that are most suitable to our clients’ needs and business agenda.

99 Wall Street ,Suite No-
527, New York, NY 10005

This release was published on openPR.